186 related articles for article (PubMed ID: 24688970)
1. Lipid profile in relation to anthropometric indices and insulin resistance in overweight women with polycystic ovary syndrome.
Saghafi-Asl M; Pirouzpanah S; Ebrahimi-Mameghani M; Asghari-Jafarabadi M; Aliashrafi S; Sadein B
Health Promot Perspect; 2013; 3(2):206-16. PubMed ID: 24688970
[TBL] [Abstract][Full Text] [Related]
2. Association of insulin resistance with lipid profile, metabolic syndrome, and hormonal aberrations in overweight or obese women with polycystic ovary syndrome.
Ebrahimi-Mamaghani M; Saghafi-Asl M; Pirouzpanah S; Aliasgharzadeh A; Aliashrafi S; Rezayi N; Mehrzad-Sadaghiani M
J Health Popul Nutr; 2015 Mar; 33(1):157-67. PubMed ID: 25995732
[TBL] [Abstract][Full Text] [Related]
3. Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome.
Fulghesu A; Magnini R; Portoghese E; Angioni S; Minerba L; Melis GB
J Adolesc Health; 2010 May; 46(5):474-81. PubMed ID: 20413084
[TBL] [Abstract][Full Text] [Related]
4. Fetuin-A and Its Association with Anthropometric, Atherogenic, and Biochemical Parameters and Indices among Women with Polycystic Ovary Syndrome.
Kulik-Kupka K; Jabczyk M; Nowak J; Jagielski P; Hudzik B; Zubelewicz-Szkodzińska B
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235688
[TBL] [Abstract][Full Text] [Related]
5. Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China.
Huang X; Wang Q; Liu T; Pei T; Liu D; Zhu H; Huang W
Endocrine; 2019 Jul; 65(1):81-85. PubMed ID: 30924083
[TBL] [Abstract][Full Text] [Related]
6. Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome.
Sam S; Scoccia B; Yalamanchi S; Mazzone T
Hum Reprod; 2015 Jun; 30(6):1358-64. PubMed ID: 25857311
[TBL] [Abstract][Full Text] [Related]
7. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
Holte J; Bergh T; Berne C; Lithell H
Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
[TBL] [Abstract][Full Text] [Related]
8. Dyslipidaemia in polycystic ovarian syndrome: different groups, different aetiologies?
Meirow D; Raz I; Yossepowitch O; Brzezinski A; Rosler A; Schenker JG; Berry EM
Hum Reprod; 1996 Sep; 11(9):1848-53. PubMed ID: 8921052
[TBL] [Abstract][Full Text] [Related]
9. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
Durmus U; Duran C; Ecirli S
J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
[TBL] [Abstract][Full Text] [Related]
10. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
Wang L; Lv S; Li F; Yu X; Bai E; Yang X
Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
[No Abstract] [Full Text] [Related]
12. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
[TBL] [Abstract][Full Text] [Related]
13. The relationship between glomerular filtration rate, and metabolic and inflammatory parameters in obese and non-obese patients with polycystic ovary syndrome.
Can M; Duran C; Guney I; Elmas H; Ayhan M; Erdem SS
Clin Investig Arterioscler; 2020; 32(6):256-262. PubMed ID: 32773256
[TBL] [Abstract][Full Text] [Related]
14. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295
[TBL] [Abstract][Full Text] [Related]
15. Dyslipidemia in relation to body mass index and insulin resistance in Chinese women with polycystic ovary syndrome.
Hong Y; Yang D; Liu W; Zhao X; Chen X; Li L
J Biol Regul Homeost Agents; 2011; 25(3):365-74. PubMed ID: 22023761
[TBL] [Abstract][Full Text] [Related]
16. Wrist circumference: A new marker for insulin resistance in African women with polycystic ovary syndrome.
Amisi CA; Ciccozzi M; Pozzilli P
World J Diabetes; 2020 Feb; 11(2):42-51. PubMed ID: 32064035
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women.
Kheirollahi A; Teimouri M; Karimi M; Vatannejad A; Moradi N; Borumandnia N; Sadeghi A
Lipids Health Dis; 2020 Nov; 19(1):235. PubMed ID: 33161896
[TBL] [Abstract][Full Text] [Related]
18. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.
Toscani M; Migliavacca R; Sisson de Castro JA; Spritzer PM
Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
[TBL] [Abstract][Full Text] [Related]
20. Metabolic Deregulations in Patients with Polycystic Ovary Syndrome.
Jabczyk M; Nowak J; Jagielski P; Hudzik B; Kulik-Kupka K; Włodarczyk A; Lar K; Zubelewicz-Szkodzińska B
Metabolites; 2023 Feb; 13(2):. PubMed ID: 36837921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
